Vimarsana
Biggest News Aggregation in the World

Michael Cooreman News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Michael Cooreman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Michael Cooreman Today - Breaking & Trending Today

INVENTIVA: Inventiva announces positive topline results from the investigator-initiated Phase II clinical trial evaluating lanifibranor in patients with T2D and NAFLD - Vimarsana News

INVENTIVA: Inventiva announces positive topline results from the investigator-initiated Phase II clinical trial evaluating lanifibranor in patients with T2D and NAFLD

Lanifibranor 800mg achieved the primary efficacy endpoint demonstrating a 44% reduction of hepatic fat measured by proton magnetic resonance spectroscopy (1H-MRS) following 24 weeks of treatment in patients

Inventiva announces positive topline results from the investigator-initiated Phase II clinical trial evaluating lanifibranor in patients with T2D and NAFLD - Vimarsana News

Inventiva announces positive topline results from the investigator-initiated Phase II clinical trial evaluating lanifibranor in patients with T2D and NAFLD

Lanifibranor 800mg achieved the primary efficacy endpoint demonstrating a 44% reduction of hepatic fat measured by proton magnetic resonance spectroscopy following 24 weeks of treatment in patients... | June 13, 2023

Inventiva announces positive topline results from the - Vimarsana News

Inventiva announces positive topline results from the

Lanifibranor 800mg achieved the primary efficacy endpoint demonstrating a 44% reduction of hepatic fat measured by proton magnetic resonance spectroscopy...

INVENTIVA: Inventiva reports 2023 First Quarter Financial Information¹ and provides a corporate update - Vimarsana News

INVENTIVA: Inventiva reports 2023 First Quarter Financial Information¹ and provides a corporate update

Cash and cash equivalents at €56.3 million, short-term deposits at €0.7 million2, and long term deposit at €9.3 million3 as of March 31, 2023, compared to €86.7 million, €1.0 million and €0.7 million as

Inventiva reports 2023 First Quarter Financial Information¹ and provides a corporate update - Vimarsana News

Inventiva reports 2023 First Quarter Financial Information¹ and provides a corporate update

Cash and cash equivalents at €56.3 million, short-term deposits at €0.7 million2, and long term deposit at €9.3 million3 as of March 31, 2023, compared to €86.7 million, €1.0... | May 16, 2023